Clinical trial
Ketamine in the Treatment of Suicidal Depression
NCT01700829
Study timeline
Study start (unknown)2012-06-01Date precision: month
Registry last updated2020-03-11
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Major Depressive Disorderunresolved
Suicidal Ideationunresolved
Interventions
KetamineDRUG · verified · RxNorm: ketamine
MidazolamDRUG · verified · RxNorm: midazolam
Sponsors & collaborators
New York State Psychiatric Institutelead sponsor
National Institute of Mental Health (NIMH)collaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT01700829 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.